Biomedical Research

Documents

FDA

Reference 22 - Gadolinium deposition in bone tissues after contrast-enhanced

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 23 - Assessment of gadolinium and iodine concentrations in kidney stones

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 24 - Effects of Gadolinium-Based MRI Contrast

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 25 - INDUCTION OF EXPRESSION OF PROFIBROTIC CYTOKINES

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 26 - Neurotoxicity from intrathecal gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 27 - Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 28 - Skin-Related Adverse Reactions in Gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 29 - Acute lung injury following gadolinium contrast

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 30 - Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 31 - Gadolinium-based contrast agent-induced neurotoxicity seeing is believing

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 32 - Caught in the act Allergic-like reaction to

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 33 - Acute respiratory distress syndrome after the use of gadolinium contrast agent.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →